Siegfried AG | Finanzwire

Basculer en Français

8299	Companies
114942	Keywords
55348	Articles
62469	Press releases

Home
Companies
Siegfried AG

BRIEF

published on 11/19/2024 at 07:08, 2 days 7 hours ago

Siegfried Opens New R&D Center for Drug Substances in Evionnaz

Pharmaceutical Industry Siegfried AG Drug Substances R&D Center Evionnaz
PRESS RELEASE

published on 11/19/2024 at 07:03, 2 days 7 hours ago

Siegfried opens new global R&D Center for Drug Substances in Evionnaz
Siegfried inaugurates new R&D Center for Drug Substances in Evionnaz, Switzerland, enhancing global development capabilities and supporting EVOLVE+ strategy

Pharmaceutical Industry Drug Substances Siegfried R&D Center Evionnaz
BRIEF

published on 11/12/2024 at 06:35, 9 days 7 hours ago

DINAMIQS Expands with New Lab in Zurich

Cell And Gene Therapy DINAMIQS Lab Siegfried Expansion Viral Vector Manufacturing Bio-Technopark Zurich
PRESS RELEASE

published on 11/12/2024 at 06:30, 9 days 7 hours ago

DINAMIQS opens new lab in Zurich
Siegfried's subsidiary DINAMIQS opens new state-of-the-art lab in Zurich Bio-Technopark, strengthening offerings in cell and gene therapy market

Cell And Gene Therapy Zurich Siegfried DINAMIQS Lab
BRIEF

published on 10/24/2024 at 06:35, 28 days 7 hours ago

Siegfried AG Unveils EVOLVE+ Strategy for Sustained Growth

Operational Excellence Strategic Development Pharmaceutical Growth EVOLVE+ Strategy CDMO Expansion
PRESS RELEASE

published on 10/24/2024 at 06:30, 28 days 7 hours ago

Strategy EVOLVE+ paves the way for continued profitable growth
Siegfried unveils EVOLVE+ strategy at Capital Markets Day, focusing on growth, technology, and operational excellence. CEO emphasizes company's strong position in the CDMO market

CDMO Strategy Growth Siegfried EVOLVE+
BRIEF

published on 09/04/2024 at 06:35, 2 months 17 days ago

EGS Beteiligungen AG Increases Stake in Siegfried to 7.2% Registered Shares

Convertible Bond Shareholding Increase EGS Beteiligungen AG Pharmaceutical Acquisition Siegfried Holding
PRESS RELEASE

published on 09/04/2024 at 06:30, 2 months 17 days ago

EGS Beteiligungen AG exercises right to convert bond and increases its shareholding in Siegfried to 7.2% registered shares
EGS Beteiligungen AG exercises conversion right of CHF 40m bond into 48,054 shares of Siegfried, increasing stake to 7.2%. Siegfried Holding AG's largest shareholder shows confidence in business model and strategy

Pharmaceutical Industry Shareholding Bond Conversion EGS Beteiligungen AG Siegfried Holding AG
BRIEF

published on 08/30/2024 at 06:35, 2 months 22 days ago

Siegfried Opens New Quality Control Lab in Minden

Operational Efficiency Pharmaceutical Technological Capabilities Quality Control Production Plant
PRESS RELEASE

published on 08/30/2024 at 06:30, 2 months 22 days ago

Siegfried opens new quality control lab in Minden
Siegfried inaugurates new state-of-the-art quality control lab in Minden, Germany, enhancing operational efficiency and preparing for new production plant

Pharmaceutical Industry Germany Siegfried Quality Control Lab Minden

Accesswire

Published on 11/21/2024 at 14:15, 11 minutes ago

neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Published on 11/21/2024 at 14:00, 26 minutes ago

Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 26 minutes ago

Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 26 minutes ago

Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 14:00, 26 minutes ago

GameSquare's Stream Hatchet Publishes Q3 Report

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 14:16, 10 minutes ago

EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 11 minutes ago

ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 14:00, 26 minutes ago

Form 8.3 - LOYS AG: Learning Technologies Group plc
Published on 11/21/2024 at 13:15, 1 hour 11 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 51 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6

Les Echos

Published on 11/21/2024 at 06:58, 7 hours 28 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 19 hours 6 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 41 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 41 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE